Toutes les études
RecrutementPHASE3INTERVENTIONNEL

Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)

This study is for people who have had successful surgery or other treatments to remove all their bowel cancer that had spread. Researchers want to find out if giving a course of chemotherapy afterward helps keep the cancer from coming back and improves their overall quality of life. Half of the people will get chemotherapy, and the other half will have regular check-ups. The study will track how well both groups do over time. It's a 'Phase 3' study, meaning it's one of the final steps to see if a new treatment approach is better than what’s currently available.

En un coup d'œil

Statut
Recrutement
Phase
PHASE3
Sponsor
Dominik Paul Modest
Objectif d'inscription
507
Démarrer
06 Dec 2021
Achèvement estimé
01 Nov 2030

De quoi parle cette étude ?

Imagine you or someone you know has bowel cancer that has spread to other parts of the body, but doctors have been able to remove all of it with surgery or other procedures. This can be a huge relief, but there's always a worry the cancer might return. This study is designed to look into whether giving a course of chemotherapy *after* all visible cancer has been removed helps keep it away for longer.

The study aims to compare two approaches: one group will receive a type of chemotherapy (either mFOLFOXIRI or mFOLFOX-6) for up to six months. The other group will just have regular check-ups and monitoring to see if the cancer returns. By comparing these two groups, doctors hope to understand if the extra chemotherapy improves patients' health and quality of life without causing too many side effects.

This kind of research is really important because it helps doctors develop the best possible treatment plans for people with bowel cancer that has spread. They want to find out if this additional treatment can give people a better chance of staying cancer-free and living well.

Points clés

  • The study is for people whose bowel cancer, which had spread, has now been fully removed.
  • It compares extra chemotherapy after surgery to regular check-ups.
  • You'll be randomly put into a group for treatment or follow-up.
  • Participation involves regular scans, blood tests, and quality of life surveys for up to 5 years.
  • The aim is to improve outcomes and quality of life for patients.
  • Your general health and blood test results need to be within specific ranges.

Qui peut être éligible ?

This study is for adults aged 18 or over. You would be considered if you have been diagnosed with bowel cancer that has spread, and all signs of the cancer have been successfully removed by surgery or other treatments. This clean-up of the cancer must have happened recently – within 3 to 10 weeks before joining the study.

It's important that you don't have any active bleeding or serious wound healing problems from your surgery when you join. Also, scans taken just before joining the study must show no remaining cancer. Your general health, including your blood test results for your kidneys, liver, and blood counts, needs to be within a healthy range to ensure you can safely receive any treatment.

Your doctor will check if you meet all the specific health requirements. For example, they'll look at how well your body processes certain medications, and your ability to carry out daily activities. These detailed checks are there to make sure the study is safe and appropriate for you.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous 18 ans ou plus ?
  2. Have you had bowel cancer that spread, and has it all been taken out by surgery or other treatments in the last 3-10 weeks?
  3. Do your recent scans show no cancer remaining?
  4. Is your general health, including your blood counts and organ function, in a good state?
  5. Are you able to manage daily activities without too much difficulty?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you join this study, you'll be randomly assigned to one of two groups, a bit like flipping a coin. Two out of three people will be in the group that receives additional treatment, and one out of three will be in the group that has active follow-up.

If you're in the treatment group, you'll receive chemotherapy (either mFOLFOXIRI or mFOLFOX-6) for up to six months, with regular check-ups to monitor your health and any side effects. If you're in the other group, you'll have regular follow-up appointments and scans.

All participants will have regular visits for check-ups, blood tests, and scans (like CT or MRI) every three months for the first two years. After that, these checks will happen every six months for up to a total of five years. During your visits, you'll also be asked questions about how you're feeling and your quality of life. Sometimes, if the cancer returns, tissue samples might be collected again if possible.

Risques et avantages potentiels

Taking part in a study like this could potentially offer benefits, such as receiving extra treatment that might help keep the cancer from returning for longer, or having very close monitoring of your health. However, there are also potential risks. The chemotherapy treatments can have side effects, which your doctor will discuss with you. You might also have more hospital visits and tests than if you weren't in the study. You have the right to leave the study at any time, for any reason, and this decision will not affect your future medical care.

Locations (79)

  • Klinikum St. Marien Amberg
    Code postal vérifié
    Amberg, Germany· Recrutement
  • Helios Klinikum Bad Saarow
    Code postal vérifié
    Bad Saarow, Germany· Recrutement
  • Klinikum Bayreuth
    Code postal vérifié
    Bayreuth, Germany· Recrutement
  • Charité Universitätsmedizin Berlin
    Code postal vérifié
    Berlin, Allemagne· Recrutement
  • Helios Klinikum Emil von Behring
    Code postal vérifié
    Berlin, Allemagne· Recrutement
  • MVZ Onkologischer Schwerpunkt am Oskar-Helene-Heim
    Code postal vérifié
    Berlin, Allemagne· Recrutement
  • Vivantes Klinikum am Urban Berlin
    Code postal vérifié
    Berlin, Allemagne· Recrutement
  • Vivantes Klinikum Spandau Berlin
    Code postal vérifié
    Berlin, Allemagne· Recrutement
  • St. Josef-Hospital Bochum
    Code postal vérifié
    Bochum, Germany· Recrutement
  • Johanniterkrankenhaus Bonn
    Code postal vérifié
    Bonn, Germany· Recrutement
  • Diakonie-Krankenhaus Bremen
    Code postal vérifié
    Brême, Allemagne· Retiré
  • Klinikum Chemnitz
    Code postal vérifié
    Chemnitz, Allemagne· Recrutement

Questions fréquentes

What does 'metastatic colorectal cancer' mean?

It means bowel cancer that has spread from its original spot to other parts of your body.

What is the aim of this study?

The study wants to see if giving chemotherapy after all spread-out cancer has been removed helps to prevent it from coming back and improves your quality of life.

Will I definitely get chemotherapy if I join?

You'll be randomly assigned to one of two groups. Two out of three people will get chemotherapy, and one out of three will have regular check-ups.

Combien de temps serai-je impliqué dans l'étude ?

The study involves regular check-ups and scans for up to five years. If you receive chemotherapy, that part of the treatment typically lasts up to six months.

What chemicals are in the chemotherapy treatments?

The chemotherapy treatments used are called mFOLFOXIRI or mFOLFOX-6. Your doctor can give you more detailed information about these medicines.

Comment en savoir plus

Dominik Modest, Prof. Dr.

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Intéressé à participer ?

Inscrivez votre intérêt

Partagez vos coordonnées et l'équipe de recherche pour "Post-resection/Ablation Chemotherapy in Patients With Metast… vous contactera si vous êtes éligible. Consultez toujours votre médecin avant d'accepter de participer.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.